Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.
XII Medical provides minimally invasive technology for obstructive sleep apnea.
Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.
CatalYm is a biotechnology company developing innovative immunotherapies for cancer patients.
Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.
Marea is a biotechnology company that develops therapies and medications for the treatment of cardioendocrine illness patients.
Eyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases.
Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases.
Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.
Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.
Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.
SoniVie Ltd develops an advanced denervation solution
Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.
Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders
Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein modifications.
GelSight provides extremely detailed and rapid surface measurements through the novel GelSight sensor technology.
etherna develops mRNA and lipid nanoparticle solutions.
CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.
Rectify Pharmaceuticals is a biotechnology company developing Positive Functional Modulators (PFMs), disease-modifying therapeutics.
Anjarium is focused on creating new class of non-viral gene therapies to deliver predictable ,inclusionary ways to tackle genetic diseases.
NeuroVision Imaging is a developer of digital imaging and diagnostic solutions for Alzheimer's disease.
Theseus Pharmaceuticals is a technology-based company.
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Omega Funds has invested in 79 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Omega Funds's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Life Science. The firm invests across 23 different industry categories.
Among tracked funding rounds, Morphic Therapeutic received $276.0M in a Post Ipo Equity round. Omega Funds's total known invested capital is $5.7B.
Omega Funds's average investment size is $96.1M across its portfolio of 79 companies.
Recent Omega Funds portfolio additions include Beta Bionics, XII Medical, Scorpion Therapeutics, CatalYm, Vanqua Bio. These companies were founded in 2020 or later.